Guidelines for clinical practice from development to use

Detalles Bibliográficos
Autor principal: Institute of Medicine (U.S.).
Autor Corporativo: Institute of Medicine (U.S.). Committee on Clinical Practice Guidelines (-)
Otros Autores: Field, Marilyn J. (Marilyn Jane) (-), Lohr, Kathleen N., 1941-
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academy Press 1992.
Edición:1st ed
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820336506719
Tabla de Contenidos:
  • ""Guidelines for Clinical Practice""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Guidelines for Clinical Practice""; ""Summary""; ""WHAT ARE PRACTICE GUIDELINES?""; ""WHY ARE POLICY MAKERS INTERESTED IN GUIDELINES?""; ""GENERAL STRENGTHS AND WEAKNESSES OF CURRENT PRACTICE GUIDELINES ACTIVITIES""; ""What Are the Strong Points of Current Efforts?""; ""What Are the Limitations of Current Efforts?""; ""IMPROVING THE DEVELOPMENT OF GUIDELINES""; ""Building a Compelling Case for Recommendations""; ""Procedural and Methodological Issues Needing Particular Attention""
  • ""At the Interface Between Development and Use""""Local Adaptation of Guidelines""; ""Inconsistent Guidelines""; ""Formatting and Disseminating Guidelines""; ""Going Further? Defining Cost-Effective and Minimum Levels of Care""; ""Doing More? Guidelines for Informed Patient Decision making""; ""ENSURING THE USE OF GOOD GUIDELINES""; ""Quality Assurance and Improvement""; ""Cost Management""; ""Risk Management and Medical Liability""; ""Information and Decision Support Systems""; ""A CRITICAL NEED: MEANS TO ASSESS THE SOUNDNESS OF GUIDELINES""; ""Assessment Instrument""
  • ""Assessment Organization""""RESEARCH AGENDA""; ""FINAL NOTE: GUIDELINES AND HEALTH CARE REFORM""; ""1 Introduction ""; ""PURPOSE OF THE REPORT""; ""WHAT ARE PRACTICE GUIDELINES?""; ""Definitions of Key Terms""; ""Desirable Attributes of Guidelines""; ""Elements of Analysis""; ""State of the Evidence""; ""Inconsistent or Conflicting Guidelines""; ""Types of Guidelines""; ""WHY ARE POLICY MAKERS INTERESTED IN GUIDELINES?""; ""WHO USES GUIDELINES AND FOR WHAT?""; ""BASIC PROPOSITIONS""; ""REPORT ORGANIZATION""; ""SUMMARY""; ""2 Developing Clinical Practice Guidelines ""
  • ""PLURALISM AND DIVERSITY IN GUIDELINES DEVELOPMENT""""PROFESSIONAL SOCIETIES AND RELATED ENTITIES""; ""How Are Professional Societies Involved?""; ""Why Are Professional Societies Involved?""; ""PUBLIC AGENCIES""; ""U.S. Public Health Service""; ""Food and Drug Administration""; ""National Institutes of Health""; ""Centers for Disease Control""; ""Agency for Health Care Policy and Research""; ""Other Public Agencies""; ""Health Care Financing Administration""; ""U.S. Preventive Services Task Force""; ""Congressional Office of Technology Assessment""
  • ""PRIVATE RESEARCH, PAYER, PROVIDER, AND OTHER GROUPS""""COSTS OF GUIDELINES DEVELOPMENT""; ""SUMMARY""; ""3 Implementing Guidelines: Overview and Illustrative Cases ""; ""GUIDELINES AND THE REAL WORLD""; ""CASE STUDIES""; ""Case Study 1: Small Internal Medicine Practice""; ""Case Study 2: Managed Care Organization""; ""Case Study 3: Academic Medical Center Hospital""; ""Case Study 4: Community Hospital""; ""Case Study 5: Nursing Home and Hospice""; ""Case Study 6: Patient""; ""GENERAL ISSUES IN IMPLEMENTATION""; ""Factors Influencing the Effective Use of Guidelines""
  • ""Strategies to Encourage Effective Use of Guidelines""